StockData
Guided Therapeutics Inc logo

Guided Therapeutics Inc (GTHP) income statement

GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.16−0.03 (-15.79%)

Close on Oct 19, 2026Market cap $15.45MP/E –Yield –

Guided Therapeutics Inc income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
75.8%
Operating margin
-303.8%
Net margin
-471.5%
Return on equity, FY2025
58.7%

Financial strength

Current ratio
0.09
Debt to equity
-0.00
Debt to assets
0.9%
Cash to current liabilities
0.2%

Valuation

P/E ratio
–
Price to sales
23.76
Price to book
–
Dividend yield
–

See a number that looks wrong?